Zaynich achieves over 97% efficacy in clinical study for meropenem-resistant gram-negative pathogens
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
Investment will fund expansion to meet rising demand for CRDMO services
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
The site’s GMP Certification has been successfully renewed
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
Acquisition expands high-value medical platform
Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Brings together industry experts to discuss preventive steps to protect pigs from African swine fever and best practises for pig farm management
Subscribe To Our Newsletter & Stay Updated